These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 12468480)

  • 1. Informing participants of allocation to placebo at trial closure: postal survey.
    Di Blasi Z; Kaptchuk TJ; Weinman J; Kleijnen J
    BMJ; 2002 Dec; 325(7376):1329. PubMed ID: 12468480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactions to treatment debriefing among the participants of a placebo controlled trial.
    Di Blasi Z; Crawford F; Bradley C; Kleijnen J
    BMC Health Serv Res; 2005 Apr; 5(1):30. PubMed ID: 15847683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Informed consent and participant perceptions of influenza vaccine trials in South Africa.
    Moodley K; Pather M; Myer L
    J Med Ethics; 2005 Dec; 31(12):727-32. PubMed ID: 16319239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Participants' experiences of being debriefed to placebo allocation in a clinical trial.
    Bishop FL; Jacobson EE; Shaw J; Kaptchuk TJ
    Qual Health Res; 2012 Aug; 22(8):1138-49. PubMed ID: 22673094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward rapproachment in the placebo control debate. A calculated compromise of power.
    Leon AC; Solomon DA
    Eval Health Prof; 2003 Dec; 26(4):404-14. PubMed ID: 14631611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does different information disclosure on placebo control affect blinding and trial outcomes? A case study of participant information leaflets of randomized placebo-controlled trials of acupuncture.
    Cheon S; Park HJ; Chae Y; Lee H
    BMC Med Res Methodol; 2018 Jan; 18(1):13. PubMed ID: 29347917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Audio-visual presentation of information for informed consent for participation in clinical trials.
    Ryan RE; Prictor MJ; McLaughlin KJ; Hill SJ
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003717. PubMed ID: 18254029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "I assumed that one was a placebo": exploring the consent process in a sham controlled acupressure trial.
    Hughes JG; Russell W; Breckons M; Richardson J; Lloyd-Williams M; Molassiotis A
    Complement Ther Med; 2014 Oct; 22(5):903-8. PubMed ID: 25440382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Communicating with participants during the conduct of multi-center clinical trials.
    Augustine EF; Dorsey ER; Hauser RA; Elm JJ; Tilley BC; Kieburtz KK
    Clin Trials; 2016 Dec; 13(6):592-596. PubMed ID: 27573636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods to increase response rates to postal questionnaires.
    Edwards P; Roberts I; Clarke M; DiGuiseppi C; Pratap S; Wentz R; Kwan I; Cooper R
    Cochrane Database Syst Rev; 2007 Apr; (2):MR000008. PubMed ID: 17443629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is recruitment more difficult with a placebo arm in randomised controlled trials? A quasirandomised, interview based study.
    Welton AJ; Vickers MR; Cooper JA; Meade TW; Marteau TM
    BMJ; 1999 Apr; 318(7191):1114-7. PubMed ID: 10213724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are subjects satisfied with the informed consent process? A survey of research participants.
    Pope JE; Tingey DP; Arnold JM; Hong P; Ouimet JM; Krizova A
    J Rheumatol; 2003 Apr; 30(4):815-24. PubMed ID: 12672205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Components of a randomized clinical trial.
    Dennison DK
    J Periodontal Res; 1997 Jul; 32(5):430-8. PubMed ID: 9266494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unblinding of trial participants to their treatment allocation: lessons from the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER).
    Dinnett EM; Mungall MM; Kent JA; Ronald ES; McIntyre KE; Anderson E; Gaw A;
    Clin Trials; 2005; 2(3):254-9. PubMed ID: 16279148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Random allocation or allocation at random? Patients' perspectives of participation in a randomised controlled trial.
    Featherstone K; Donovan JL
    BMJ; 1998 Oct; 317(7167):1177-80. PubMed ID: 9794849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Communicating clinical trial results to research participants.
    Dorsey ER; Beck CA; Adams M; Chadwick G; de Blieck EA; McCallum C; Briner L; Deuel L; Clarke A; Stewart R; Shoulson I;
    Arch Neurol; 2008 Dec; 65(12):1590-5. PubMed ID: 19064746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Informed consent: study of quality of information given to participants in a clinical trial.
    Lynöe N; Sandlund M; Dahlqvist G; Jacobsson L
    BMJ; 1991 Sep; 303(6803):610-3. PubMed ID: 1932901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding of placebo controls among older people with schizophrenia.
    Dunn LB; Palmer BW; Keehan M
    Schizophr Bull; 2006 Jan; 32(1):137-46. PubMed ID: 16177271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lay conceptions of the ethical and scientific justifications for random allocation in clinical trials.
    Robinson EJ; Kerr C; Stevens A; Lilford R; Braunholtz D; Edwards S
    Soc Sci Med; 2004 Feb; 58(4):811-24. PubMed ID: 14672595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Informed patient consent to participation in cluster randomized trials: an empirical exploration of trials in primary care.
    Eldridge SM; Ashby D; Feder GS
    Clin Trials; 2005; 2(2):91-8. PubMed ID: 16279130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.